(Q36294794)

13 August 2017

1 reference

title

Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models (English)

1 reference

13 August 2017

1 reference

1 reference

Marc Boogaerts

1

1 reference

13 August 2017

Moshe Mittelman

series ordinal

2

1 reference

13 August 2017

Peter Vaupel

series ordinal

3

1 reference

13 August 2017

language of work or name

1 reference

21 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

69 Suppl 2

1 reference

13 August 2017

page(s)

22-30

1 reference

Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy

13 August 2017

cites work

1 reference

The pleiotropic effects of erythropoietin in the central nervous system

21 January 2018

1 reference

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

21 January 2018

1 reference

In vivo evidence that erythropoietin protects neurons from ischemic damage

21 January 2018

1 reference

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

21 January 2018

1 reference

Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery

21 January 2018

1 reference

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

21 January 2018

1 reference

Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings.

21 January 2018

1 reference

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

21 January 2018

1 reference

Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level?

21 January 2018

1 reference

Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications

21 January 2018

1 reference

Treatment resistance of solid tumors: role of hypoxia and anemia

21 January 2018

1 reference

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

21 January 2018

1 reference

Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia

21 January 2018

1 reference

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

21 January 2018

1 reference

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

21 January 2018

1 reference

Pediatric Tumor Cells Express Erythropoietin and a Functional Erythropoietin Receptor that Promotes Angiogenesis and Tumor Cell Survival

21 January 2018

1 reference

Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation

21 January 2018

1 reference

Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice

21 January 2018

1 reference

Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia

21 January 2018

1 reference

Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies

21 January 2018

1 reference

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000088285

1 reference

13 August 2017

1 reference